PE anti-human HLA-A,B,C Antibody

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, has awarded a Purchase Order (PO) 4800145256 to BioLegend Inc., a biotechnology company based in Pasadena, California. The contract involves the procurement of two units of PE anti-human HLA-A,B,C Antibody, with a unit price of $216.00, resulting in a total contract value of $432.00. The delivery is scheduled for September 30, 2025, with goods to be shipped to UNMC Shipping and Receiving at 601 S Saddle Creek Rd, Omaha, NE 68106, specifically to the unloading point of BCC 8.12.384 AAT Hollings.

The purchase order is governed by the University of Nebraska's Standard Terms of Purchase, with Net 30 payment terms. The contract appears to be a targeted procurement of specialized laboratory antibodies, likely for research or diagnostic purposes within the medical center's facilities. The transaction is tax-exempt and includes specific instructions for packaging, invoicing, and payment procedures, reflecting standard practices for government and institutional scientific equipment procurement.